Case Report: Hepatoid adenocarcinoma of the stomach mimicking primary ovarian cancer: long-term survival following multimodal conversion immunochemotherapy
Background Hepatoid adenocarcinoma of the stomach (HAS) is a rare, highly aggressive malignancy with no established standardized first-line treatment. Advanced HAS is typically associated with a dismal prognosis. Case presentation We report a 54-year-old female with HAS (cT3N+M1) featuring a primary lesion in the gastric body, massive ascites, and ovarian metastasis (Krukenberg tumor). Following a multidisciplinary team (MDT) evaluation, the patient received five cycles of conversion therapy using the PD-1 inhibitor sintilimab combined with the SOX regimen (S-1 and oxaliplatin), with two cycles of hyperthermic intraperitoneal chemotherapy (HIPEC) administered during these five cycles to manage ascites. After adnexectomy for symptomatic ovarian metastasis, three further cycles of sintilimab, oxaliplatin, and capecitabine were administered before gastrectomy. Results The treatment course was associated with descriptive tumor regression on imaging and declining tumor markers, followed by laparoscopic radical gastrectomy and D2 lymphadenectomy with microscopically negative gastric resection margins. Postoperative histopathology showed residual tumor (ypT1bN0); the overall disease remained M1 because of the previously confirmed ovarian metastasis. During the documented follow-up, no recurrence was identified on the latest CT on January 26, 2026, approximately 29 months after gastrectomy. Conclusion This case suggests that PD-1 inhibition combined with chemotherapy may have contributed to tumor regression and sustained disease control, although its independent contribution cannot be determined.
Authors
- Hairong Li (ORCID: https://orcid.org/0000-0001-6098-1689)
- Kejian Zou
- Longfei Ding (ORCID: https://orcid.org/0000-0002-7660-0876)
- Xionghui He
- Xian-Wen Liang (ORCID: https://orcid.org/0088-0000-8800-8800)
- Xianghui Fu (ORCID: https://orcid.org/0000-0001-9808-3892)
Institutions
- Hainan General Hospital (CN)
- Hainan Medical University (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2026-11-19
- DOI
- https://doi.org/10.3389/fimmu.2026.1895585
- Primary Topic
- Gastric Cancer Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00